The cross-talk between DYRK1B and the MAPK pathway was further explored in ovarian cancer and NSCLC cell lines, where DYRK1B knockdown increased c-RAF and ERK activation [107]. The gene discussed is DYRK1B; the disease is ovarian carcinoma.